NCT01981863View on ClinicalTrials.gov

Fibrinolysis Before Cardiopulmonary Bypass?

PHASE4CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

July 31, 2013

Primary Completion Date

February 28, 2014

Study Completion Date

February 28, 2014

Conditions
Pathologic Fibrinolysis
Interventions
DRUG

Epsilonaminocaproic acid

One group receives Epsilonaminocaproic acid, 10 gr IV bolus, followed by 1 gr/hr. Second group receives placebo.

DRUG

Placebo

Placebo administered in same volume as in experimental arm.

Trial Locations (1)

94305

Stanford Hospital & Clinics, Stanford

All Listed Sponsors
lead

Stanford University

OTHER

NCT01981863 - Fibrinolysis Before Cardiopulmonary Bypass? | Biotech Hunter | Biotech Hunter